Home

Christopher L Gaenzle

CIK 1624044 · EVP, CAO & General Counsel · last filed 2021-07-01

Christopher L Gaenzle is an EVP, CAO & General Counsel who has filed 27 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for PRAH, was dated Jul 1, 2021. Across all open-market trades the lifetime net is −$18.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $67.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$67.8K

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$18.07M

Filer Profile

Reported Address
C/O INC RESEARCH HOLDINGS, INC.
3201 BEECHLEAF COURT, SUITE 600
RALEIGH, NC 27604
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRA Health Sciences, Inc. (PRAH) Delisted EVP, CAO & General Counsel 0 $165.21 $0 -$10.16M 7 2021-07-01
Syneos Health, Inc. (SYNH) Delisted CAO, GC & Sec 52,722 $42.98 $2.27M -$60.3K 2 2018-01-30
INCR CAO, GC & Sec 12,116 $5.60 $67.8K -$7.85M 18 2017-09-19

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-01 PRA Health Sciences, Inc. (PRAH) Delisted Disp (D) −34,500 $0 EDGAR
2021-06-21 PRA Health Sciences, Inc. (PRAH) Delisted Mixed — -$1.86M EDGAR
2021-06-17 PRA Health Sciences, Inc. (PRAH) Delisted Mixed −1,973 -$2.12M EDGAR
2021-06-03 PRA Health Sciences, Inc. (PRAH) Delisted Mixed +1,973 -$144.9K EDGAR
2021-01-11 PRA Health Sciences, Inc. (PRAH) Delisted Sell (S) −3,136 -$407.8K EDGAR
2020-08-17 PRA Health Sciences, Inc. (PRAH) Delisted Sell (S) −1,364 -$140.3K EDGAR
2020-06-03 PRA Health Sciences, Inc. (PRAH) Delisted Grant (A) — $0 EDGAR
2018-01-30 Syneos Health, Inc. (SYNH) Delisted Tax (F) −912 -$37.2K EDGAR
2018-01-23 Syneos Health, Inc. (SYNH) Delisted Mixed −2,263 -$92.7K EDGAR
2017-09-19 INCR Mixed −8,927 -$488.3K EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.